The EIF2B5 gene helps control how cells make proteins during stress, and certain variants can cause brain cells to struggle under strain, leading to vanishing white matter disease. The protein made by this gene helps your cells adjust when energy is low, infection occurs, or the body is under other stress. People with disease-causing EIF2B5 variants may have problems with movement, coordination, muscle tone, or learning, and symptoms can worsen after fever or a minor head injury.
What is a gene?
Genes are stretches of DNA that carry instructions your cells use to make molecules or regulate activities in the body. Some genes provide the information needed to produce proteins, the working parts of cells. Others mainly direct when certain processes happen, where they occur, and how strongly they operate. Together, genes affect how the body develops and works, and they can influence how you respond to food, stress, or medications. You can find more about this topic in the LearnHub.
Overview
EIF2B5Gene function
What if the gene works
The EIF2B5 gene helps cells make proteins by resetting a key step in protein production. It also supports how cells slow protein making during stress and restart it afterward.
Risk
What if the gene does not work
Variants in the EIF2B5 gene can cause vanishing white matter disease, affecting brain white matter. Effects range from severe childhood forms to milder adult onset forms. Some women also develop ovarian insufficiency, and illness or head injury can trigger worsening.
Treatment
What does that mean for your treatment
No EIF2B5-specific treatment or drug-selection approach is currently established for people with a pathogenic variant in the EIF2B5 gene. The EIF2B5 gene is being studied as part of the cell stress response pathway, and compounds that may calm this pathway are still in early research.
Conditions associated with EIF2B5
Gene function
What if the gene works
Your cells constantly make proteins for repair, growth, and everyday upkeep. The EIF2B5 gene supports a key control step in that process by helping cells pause and restart protein production at the right time. This steady control is central to normal EIF2B5 gene function in protein production across many tissues.
The EIF2B5 gene makes one part of eIF2B, a protein team that controls the first step of protein production. Its protein provides much of the activity needed for that control.
Its protein helps reset eIF2, a helper that delivers the first building block for a new protein. This lets cells begin another round of protein making.
When cells face strain such as low nutrients, protein production needs to slow and then recover in an orderly way. The EIF2B5 gene helps manage that shift so cells can match protein output to their needs.
What is a variant?
A genetic variant is a minor change in the DNA sequence within a gene. These changes are common and help explain normal differences between people, such as appearance, metabolism, or the way the body reacts to environmental influences. Many variants do not cause any noticeable effects and are simply part of natural genetic variation. Sometimes, though, a variant changes how a gene works to a greater extent and can contribute to or cause a genetic condition.
Genetic variants
What if the gene does not work
Variants in the EIF2B5 gene can make the cell’s protein making system less steady during stress, which is central to how EIF2B5 gene variants affect protein production under stress. Many changes weaken the EIF2B protein complex, so it is less stable or less active, while some more disruptive variants can leave very little function. Milder variants may preserve some activity, whereas more severe variants often link to earlier onset and a broader or more intense pattern of EIF2B related leukodystrophy, also called vanishing white matter disease.
How variants are linked to conditions
Pathogenic variants in the EIF2B5 gene cause EIF2B5-related vanishing white matter disease, an inherited leukodystrophy that may begin in infancy, childhood, or adulthood. This condition is linked to problems with balance, walking, muscle stiffness, weakness, and periods of sudden worsening after fever, minor head injury, or major stress. In some females, variants in the EIF2B5 gene are also associated with ovarian failure, sometimes called ovarioleukodystrophy. The age of onset and severity can vary widely, even within the same family.
A variant is not necessarily a diagnosis
Genetic variants are a normal feature of human biology and are common throughout the general population. Most do not have a direct effect on health and simply reflect natural human diversity. For many genes, carrying a variant associated with a condition suggests a possible link rather than a definite diagnosis, especially when several genes and environmental factors are involved. In some situations, though, a single well-characterized variant in a specific gene can be enough to confirm a diagnosis.
Are there things that can increase or change my risk?
For EIF2B5-related white matter disease, the main risk comes from inheriting harmful changes in both copies of the gene. Day-to-day health events can still affect how symptoms unfold: fever, infections, head injury, and other major physical stress can trigger sudden worsening. Avoiding these triggers when possible and getting prompt care for illness can help lower the chance of complications.
Inheritance of EIF2B5 variants
Variants in the EIF2B5 gene are inherited in an autosomal recessive pattern. This means a child usually needs to inherit one changed copy from each parent to have an EIF2B5-related condition, while parents with one changed copy are typically carriers. When both parents are carriers, each pregnancy has a 25% chance of the child inheriting both changed copies, a 50% chance of being a carrier, and a 25% chance of inheriting two usual copies. This EIF2B5 inheritance pattern applies to the well-established conditions linked to this gene, including vanishing white matter disease.
What does my EIF2B5 result mean for my family?
Changes in the EIF2B5 gene are most often linked to a condition that runs in families in a recessive way. For family members, this usually means parents may be healthy carriers, brothers and sisters could also be affected or be carriers, and other relatives may carry the same gene change. A child’s future risk in the wider family depends on whether both parents carry an EIF2B5 change.
Genetic information
Genetic testing
How you find out about variants
To look for changes in the EIF2B5 gene, doctors use EIF2B5 genetic testing on a blood or saliva sample. A lab reads the DNA code to check for variants, and results can show whether a person carries a variant linked to an EIF2B-related white matter condition, alongside symptoms and family history.
When should I consider getting a genetic test?
Consider testing for the EIF2B5 gene if there are signs of a rare inherited condition that affects the brain’s white matter, causing movement problems, stiffness, weakness, or a loss of skills, especially after fever or minor head injury. Testing can also help when this condition runs in the family or a relative already has an EIF2B5 change.
A genetic result is only one part of your health story
Genetic results can provide useful insight, but how much they reveal varies by the condition and the specific type of variant. Over time, many factors, including lifestyle, environment, age, and medical history, also affect how the body functions. For some conditions, especially those shaped by many genes, genetic information provides context rather than certainty and is most helpful when viewed together with other parts of care. In other situations, a genetic result can offer a clear answer. In areas like medication response, genetic results can also help put a person’s experiences into context.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can influence how your body responds to medicines. Small differences in genes can affect how a drug is absorbed, broken down, moved through the body, or how strongly it acts on its target. This helps explain why the same medication may work well for one person, seem weaker for another, or cause more side effects in someone who is more sensitive to it.
What is Pharmacogenetics?
Pharmacogenetics examines the way genetic differences can affect a person’s response to medicines. It studies relationships between genes and drugs to help explain why the same treatment may work differently in different people. For many medicines, genes can influence either how powerfully a drug works or how the body handles it. This information can support treatment choices that are more informed and more individualized. To look into this subject more closely, you can learn more in the LearnHub.
Drugs influenced by the EIF2B5 gene
When should I seek medical advice?
There is not yet a broadly confirmed role for this gene in predicting how medicines will work, so questions about side effects, new symptoms, or changes to your treatment are best discussed with your doctor.
History
EIF2B5 entered medical genetics through research on children and adults with a rare brain white matter condition now called vanishing white matter disease. In the late 1990s and early 2000s, scientists linked changes in the EIF2B5 gene, along with related EIF2B genes, to this condition and helped clarify that what looked like several separate illnesses belonged to the same spectrum. Initially understood only through visible traits, later recognized as tied to a specific gene, the condition became easier to classify more consistently. From these first observations, research expanded steadily. The discovery was an important step because it connected careful brain scan findings with inherited causes and gave families a clearer explanation for an often confusing diagnosis.